MurE inhibitors as antibacterial agents: a review

Peptidoglycan, an essential component of the bacterial cell wall plays a critical role in protecting bacteria against osmotic lysis. The ATP-dependent MurC-F ligases are crucial for the early stages of peptidoglycan biosynthesis. MurE ligase is third in the series and catalyzes the addition of l-Lysine (l-Lys) in Gram-positive bacteria or meso-diaminopimelic acid (meso-A2pm) in most Gram-negative bacteria to form UDP-N-acetylmuramoyl-l-Ala-d-Glu-l-Lys/A2pm. The high substrate specific for l-Lys or meso-A2pm makes this enzyme an attractive target for the development of antibacterial agents. Several MurE inhibitors have been reported including phosphinates, peptidosulfonamides, napthylfuran-2-ones, benzene-1,3-dicarboxylic acids, phosphorylatedhydroxyethylamines, natural compounds, 5-benzylidenethiazolidin-4-ones, N-alkyl-2-alkynyl-4(1H)-quinolones, rhodanine substituted d-glutamic acids, 2,5-dimethyl pyrroles, 2,5-disubstitued furans, tetrahydroisoquinolines etc. In the present review we present an update status and structural information of MurE enzyme inhibitors which may be utilized for the design of potent inhibitors against this enzyme.

[1]  I. A. Rose,et al.  A stereochemical method for detection of ATP terminal phosphate transfer in enzymatic reactions. Glutamine synthetase. , 1976, The Journal of biological chemistry.

[2]  J. Villafranca,et al.  Kinetic mechanism of Escherichia coli glutamine synthetase. , 1980, Biochemistry.

[3]  J. Villafranca,et al.  Escherichia coli glutamine synthetase. Determination of rate-limiting steps by rapid-quench and isotope partitioning experiments. , 1982, Biochemistry.

[4]  U. Schwarz,et al.  The composition of the murein of Escherichia coli. , 1988, The Journal of biological chemistry.

[5]  C. Walsh,et al.  Kinetic evidence for the formation of D-alanyl phosphate in the mechanism of D-alanyl-D-alanine ligase. , 1990, The Journal of biological chemistry.

[6]  C. Walsh,et al.  Molecular studies on trypanothione reductase, a target for antiparasitic drugs. , 1991, Trends in biochemical sciences.

[7]  C. Walsh,et al.  D-Alanyl-D-alanine ligases and the molecular mechanism of vancomycin resistance , 1992 .

[8]  H. Kato,et al.  MECHANISM-BASED INACTIVATION OF GLUTATHIONE SYNTHETASE BY PHOSPHINIC ACID TRANSITION-STATE ANALOGUE , 1994 .

[9]  T. Tanaka,et al.  Flexible loop that is novel catalytic machinery in a ligase. Atomic structure and function of the loopless glutathione synthetase. , 1994, Biochemistry.

[10]  C. Walsh,et al.  Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 A resolution. , 1994, Science.

[11]  C. Walsh,et al.  Active site mapping of Escherichia coli D-Ala-D-Ala ligase by structure-based mutagenesis. , 1995, Biochemistry.

[12]  H. T. Ho,et al.  Biochemical evidence for the formation of a covalent acyl-phosphate linkage between UDP-N-acetylmuramate and ATP in the Escherichia coli UDP-N-acetylmuramate:L-alanine ligase-catalyzed reaction. , 1996, Biochemistry.

[13]  D. Blanot,et al.  Study of the reaction mechanism of the D-glutamic acid-adding enzyme from Escherichia coli. , 1996, Microbial drug resistance.

[14]  Robert M. Williams,et al.  Asymmetric Syntheses of (2S,3S,6S)-, (2S,3S,6R)-, and (2R,3R,6S)-2,3-Methano-2,6-diaminopimelic Acids. Studies Directed to the Design of Novel Substrate-based Inhibitors of L,L-Diaminopimelate Epimerase , 1996 .

[15]  J. Vederas,et al.  Effect of analogues of diaminopimelic acid on the meso‐diaminopimelate‐adding enzyme from Escherichia coli , 1996, FEBS letters.

[16]  H. Kato,et al.  Mechanism-based inactivation of E. coli γ-glutamylcysteine synthetase by phosphinic acid- and sulfoximine-based transition-state analogues , 1996 .

[17]  D. Blanot,et al.  Phosphinate Inhibitors of the D-Glutamic Acid-Adding Enzyme of Peptidoglycan Biosynthesis. , 1996, The Journal of organic chemistry.

[18]  D. Mengin-Lecreulx,et al.  Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc:L-alanine ligase from Escherichia coli. , 1997, Biochemistry.

[19]  D. Pompliano,et al.  Conditionally lethal Escherichia coli murein mutants contain point defects that map to regions conserved among murein and folyl poly-gamma-glutamate ligases: identification of a ligase superfamily. , 1997, Biochemistry.

[20]  Kenny K. Wong,et al.  A Phosphinate Inhibitor of the meso-Diaminopimelic Acid-Adding Enzyme (MurE) of Peptidoglycan Biosynthesis , 1998 .

[21]  S. Reddy,et al.  Inhibitors of the bacterial cell wall biosynthesis enzyme MurD. , 1998, Bioorganic & medicinal chemistry letters.

[22]  David John Adams,et al.  Expression of the Staphylococcus aureusUDP-N-Acetylmuramoyl- l-Alanyl-d-Glutamate:l-Lysine Ligase in Escherichia coli and Effects on Peptidoglycan Biosynthesis and Cell Growth , 1999, Journal of bacteriology.

[23]  D. Blanot,et al.  Formation of adenosine 5′‐tetraphosphate from the acyl phosphate intermediate: a difference between the MurC and MurD synthetases of Escherichia coli , 1999, FEBS letters.

[24]  E. Baker,et al.  Structural and functional similarities in the ADP-forming amide bond ligase superfamily: implications for a substrate-induced conformational change in folylpolyglutamate synthetase. , 2000, Journal of molecular biology.

[25]  J. Heijenoort,et al.  Evidence of a functional requirement for a carbamoylated lysine residue in MurD, MurE and MurF synthetases as established by chemical rescue experiments. , 2001, European journal of biochemistry.

[26]  O. Dideberg,et al.  Crystal Structure of UDP-N-acetylmuramoyl-l-alanyl-d-glutamate:meso-Diaminopimelate Ligase from Escherichia Coli * , 2001, The Journal of Biological Chemistry.

[27]  D. Blanot,et al.  MurC and MurD synthetases of peptidoglycan biosynthesis: borohydride trapping of acyl-phosphate intermediates. , 2002, Methods in enzymology.

[28]  R. Levesque,et al.  Structure and function of the Mur enzymes: development of novel inhibitors , 2002, Molecular microbiology.

[29]  A. Salvator,et al.  Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli , 2003, The Pediatric infectious disease journal.

[30]  M. Jacobs Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children , 2003, The Pediatric infectious disease journal.

[31]  L. Silver Novel inhibitors of bacterial cell wall synthesis. , 2003, Current opinion in microbiology.

[32]  H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[33]  D. Pompliano,et al.  Cloning, expression and characterization of the Streptococcus pyogenes murE gene encoding a UDP-MurNAc-l-alanyl-d-glutamate: l-lysine ligase , 2004 .

[34]  P. Hajduk,et al.  Structure of MurF from Streptococcus pneumoniae co‐crystallized with a small molecule inhibitor exhibits interdomain closure , 2005, Protein Science.

[35]  D. Blanot,et al.  A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial peptidoglycan biosynthesis enzymes MurD and MurE , 2006 .

[36]  D. Mengin-Lecreulx,et al.  The MurE Synthetase from Thermotoga maritima Is Endowed with an Unusual d-Lysine Adding Activity* , 2006, Journal of Biological Chemistry.

[37]  L. Silver Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? , 2006, Biochemical pharmacology.

[38]  Clyde A. Smith Structure, function and dynamics in the mur family of bacterial cell wall ligases. , 2006, Journal of molecular biology.

[39]  D. Blanot,et al.  Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. , 2006, Bioorganic & medicinal chemistry letters.

[40]  C. Caufield,et al.  Naphthyl Tetronic Acids as Multi‐Target Inhibitors of Bacterial Peptidoglycan Biosynthesis , 2007, ChemMedChem.

[41]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[42]  T. Šolmajer,et al.  Targeted molecular dynamics simulation studies of binding and conformational changes in E. coli MurD , 2007, Proteins.

[43]  K. Bush,et al.  A MurF Inhibitor That Disrupts Cell Wall Biosynthesis in Escherichia coli , 2007, Antimicrobial Agents and Chemotherapy.

[44]  D. Blanot,et al.  Cytoplasmic steps of peptidoglycan biosynthesis. , 2008, FEMS microbiology reviews.

[45]  S. Turk,et al.  Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. , 2009, Bioorganic chemistry.

[46]  K. Bush,et al.  MurF Inhibitors with Antibacterial Activity: Effect on Muropeptide Levels , 2009, Antimicrobial Agents and Chemotherapy.

[47]  G. Wolber,et al.  Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach. , 2009, Bioorganic & medicinal chemistry letters.

[48]  S. Turk,et al.  5‐Benzylidenethiazolidin‐4‐ones as Multitarget Inhibitors of Bacterial Mur Ligases , 2010, ChemMedChem.

[49]  S. Bhakta,et al.  Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. , 2010, The Journal of antimicrobial chemotherapy.

[50]  R. Bauer,et al.  Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics , 2011, The Journal of antimicrobial chemotherapy.

[51]  R. Bauer,et al.  Synthesis and Antibacterial Evaluation of a New Series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones , 2012, Molecules.

[52]  S. Bhakta,et al.  An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis , 2012, International journal of antimicrobial agents.

[53]  C. Contreras-Martel,et al.  Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus. , 2011, ACS medicinal chemistry letters.

[54]  V. Fülöp,et al.  Specificity Determinants for Lysine Incorporation in Staphylococcus aureus Peptidoglycan as Revealed by the Structure of a MurE Enzyme Ternary Complex* , 2013, The Journal of Biological Chemistry.

[55]  K. Lewis Platforms for antibiotic discovery , 2013, Nature Reviews Drug Discovery.

[56]  G. Wolber,et al.  Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF). , 2014, Bioorganic & medicinal chemistry.

[57]  Catherine Paradis-Bleau,et al.  The biology of Mur ligases as an antibacterial target , 2014, Molecular microbiology.

[58]  S. Gobec,et al.  Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F. , 2014, Bioorganic chemistry.

[59]  R. Angell,et al.  Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase , 2015, The Journal of antimicrobial chemotherapy.

[60]  Simona Golic Grdadolnik,et al.  Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC–MurF): experimental and computational characterization , 2015, Journal of Computer-Aided Molecular Design.

[61]  S. Grdadolnik,et al.  Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases , 2019, Journal of enzyme inhibition and medicinal chemistry.